After @ years of ZOL , in women who have a TH t-score above -@ , no recent incident fracture and no more than one risk factor ( almost @ % of the population ) , risk for subsequent fracture ( over three additional years ) is low if treatment is discontinued ( for MorphVertFx , average risk @ % and for NVF , average risk @ % ) .